Significado clínico da hipertensão durante o sono / Clinical meaning of hypertension during sleep

A anormalidade da pressão arterial durante o período de sono identificada como médias ≥ 120 x 70 mm Hg, por meio de registros da Monitorização Ambulatorial da Pressão Arterial de 24 horas (MAPA), está relacionada a pior prognóstico e maior risco de eventos. Essa alteração pode ser decorrência de vários fatores, mas, geralmente, independentemente da causa está fortemente relacionada a maior probabilidade de eventos e mortalidade cardiovasculares. Ainda restam dúvidas, embora evidências começam a ser oferecidas, se o tratamento medicamentoso desse estado de comportamento peculiar da pressão arterial nas 24 horas deva ser instituído. Nessa revisão esses aspectos são amplamente discutidos com base nas melhores evidências disponíveis

The abnormality of blood pressure during the sleep period identified as means ≥ 120 x 70 mm Hg, through 24-hour Ambulatory Blood Pressure Monitoring (ABPM) records, is related to a worse prognosis and greater risk of events. This change can be due to several factors, but, generally, regardless of the cause, it is strongly related to a higher probability of cardiovascular events and mortality. Doubts remain, although evidence is beginning to be offered, whether drug treatment of this peculiar behavioral state of blood pressure within 24 hours should be instituted. In this review, these aspects are widely discussed based on the best available evidence

Impact of Different Normality Thresholds for 24-hour ABPM at the Primary Health Care Level / Impacto de Diferentes Limiares de Normalidade para a MAPA de 24 Horas no Nível de Atenção Primária à Saúde

Abstract Background: Hypertension is an important risk factor for cardiovascular outcomes. Primary health care (PHC) physicians should be prepared to act appropriately in the prevention of cardiovascular risk factors. However, the rates of patients with control of blood pressure (BP) remain low. The impact of the reclassification of high BP by 24-hour ambulatory BP monitoring (ABPM) can lead to different medical decisions in PHC. Objective: To evaluate the agreement between the BP measured by a conventional method by PHC physicians and by 24-hour ABPM, considering different BP normal thresholds for the 24-hour ABPM according to the V Brazilian ABPM Guidelines and the European Society of Hypertension Guidelines. Methods: A cross-sectional study including 569 hypertensive patients. The BP was initially measured by the PHC physicians and, later, by 24-hour ABPM. The BP measurements were obtained independently between the two methods. The therapeutic targets for the conventional BP followed the guidelines by the Eighth Joint National Committee (JNC 8), the V ABPM Brazilian Guidelines, and the 2013 European Hypertension Guidelines. Results: There was an accuracy of 54.8% (95% confidence interval [95%CI] 0.51 - 0.58%) for the BP measured with the conventional method when compared with the 24-hour ABPM, with a sensitivity of 85% (95%CI 80.8 - 88.6%), specificity of 31.9% (95%CI 28.7 - 34.7%), and kappa value of 0.155, when considering the European Hypertension Guidelines. When using more stringent thresholds to characterize the BP as "normal" by ABPM, the accuracy was 45% (95%CI 0.41 - 0.47%) for conventional measurement when compared with 24-hour ABPM, with a sensitivity of 86.7% (95%CI 0.81 - 0.91%), specificity of 29% (95%CI 0.26 - 0.30%), and kappa value of 0.103. Conclusion: The BP measurements obtained by PHC physicians showed low accuracy when compared with those obtained by 24-hour ABPM, regardless of the threshold set by the different guidelines.

Resumo Fundamentos: A hipertensão arterial sistêmica é um fator de risco importante para desfechos cardiovasculares. Médicos da atenção primária à saúde (APS) devem estar preparados para atuar adequadamente na prevenção de fatores de risco cardiovascular. No entanto, as taxas de pacientes com pressão arterial (PA) controlada continuam baixas. O impacto da reclassificação do diagnóstico de hipertensão pela utilização da monitorização ambulatorial da PA (MAPA) de 24 horas pode levar a diferentes decisões médicas na APS. Objetivo: Avaliar a concordância entre as PAs medidas por método convencional por médicos da APS e por MAPA de 24 horas, considerando diferentes limiares de normalidade para a MAPA de 24 horas de acordo com as recomendações da V Diretriz Brasileira de MAPA e da Diretriz da Sociedade Europeia de Hipertensão. Métodos: Estudo transversal com 569 pacientes hipertensos. A PA foi medida inicialmente por médicos da APS e, posteriormente, pela MAPA de 24 horas. As medidas foram obtidas de forma independente entre os dois métodos. Os alvos terapêuticos para a PA convencional seguiram as orientações do Eighth Joint National Committee (JNC 8), das V Diretrizes Brasileiras de MAPA e das Diretrizes Europeias de Hipertensão de 2013. Resultados: Foi observada uma acurácia de 54,8% (intervalo de confiança de 95% [IC95%] 0,51 - 0,58%) para a PA aferida de forma convencional quando comparada à obtida com a MAPA de 24 horas, além de uma sensibilidade de 85% (IC95% 80,8 - 88,6%), especificidade de 31,9% (IC95% 28,7 - 34,7%) e kappa de 0,155, quando consideradas as Diretrizes Europeias de Hipertensão. Quando utilizados limiares mais rígidos para caracterizar a PA como "normal" pela MAPA, foi identificada uma acurácia de 45% (IC95% 0,41 - 0,47%) pela medida convencional quando comparada à obtida pela MAPA de 24 horas, além de uma sensibilidade de 86,7% (IC95% 0,81 - 0,91%), especificidade de 29% (IC95% 0,26 - 0,30%) e kappa de 0,103. Conclusão: As medidas de PA avaliadas pelos médicos da APS apresentaram baixa acurácia quando comparadas às medidas pela MAPA de 24 horas, independente do limiar utilizado pelas diferentes diretrizes.

Avaliação dos níveis pressóricos em pacientes submetidos a tratamento cirúrgico ambulatorial / Evaluation of blood pressure in patients undergoing ambulatory surgery

O objetivo foi investigar e comparar as alterações da pressão arterial em pacientes hipertensos e normotensos submetidos à cirurgia odontológica em âmbito ambulatorial. A amostra foi constituída por dois grupos: Grupo Normotenso e Grupo Hipertenso (com 8 indivíduos em cada grupo). Pacientes foram avaliados pela Monitorizarão Ambulatorial da Pressão Arterial (MAPA) durante 24 horas. As aferições constadas no exame foram divididas para análise dos dados em 5 momentos: sono, pré-cirúrgico, transcirúrgico, pós-cirúrgico e vigília. Houve aumento significativo da pressão arterial no momento transcirúrgico do Grupo Normotenso (p = 0,02) e do Grupo Hipertenso (p = 0,04). No momento transcirúrgico notou-se o aumento significativo da pressão arterial nos dois grupos, todavia o grupo hipertenso manteve seus índices pressóricos elevados por maior fração de tempo.

The objective was investigated and compare the blood pressure variances in hypertensive and regular blood pressure patients who went thru dental surgery at ambulatory environment. The sample was made of two different groups: Regular Blood Pressure Group and Hypertensive Group (with 8 individuals on each group). Patients were evaluated by Blood Pressure Ambulatory Monitoring for 24 hours. The readings observed at the exam were divided in 5 moments: sleep, Pre-Operatory, Trans-Operatory, Post-Operatory and Follow Up. There was a significant increase observed at the Blood Pressure reading at the Trans-operatory of the Regular Blood Pressure group (p = 0,02) and the Hypertensive Group (p = 0,04). During the trans- -operatory it was observed a significant increase of the Blood Pressure on both groups, but the Hypertensive Group kept their numbers elevated for a longer time.

Papel da monitorização ambulatorial da pressão arterial na HAS de difícil controle / Role of ambulatory blood pressure monitoring in hard-to-control hypertension

Hipertensão permanece não controlada na maioria dos pacientes que utilizam tratamento antihipertensivo. Pacientes tratados com hipertensão não controlada freqüentemente têm múltiplos fatores de risco cardiovascular. Além disso, vários estudos observacionais têm demonstrado que a maioria dos pacientes com hipertensão não controlada não recebem terapia tríplice incluindo um diurético. A hipertensão resistente tem sido diferenciada em hipertensão verdadeiramente resistente e hipertensão do avental branco através do uso da monitorização ambulatorial da pressão arterial (MAPA). A MAPA, dessa forma, apresenta um papel importante no diagnóstico preciso de hipertensão resistentes auxiliando na utilização racional do tratamento medicamentoso.

Hypertension remains uncontrolled in most of the patients treated with antihypertensive drugs. Treated patients with uncontrolled hypertension often have multiple risk factors of cardiovascular risk. Moreover, many observational studies have shown that most of the patients with uncontrolled hypertension do not receive triple therapy including an antidiuretic. Resistant hypertension has been distinguished from truly resistant hypertension and white coat hypertension through ambulatory blood pressure monitoring (ABPM). Thus, ABMP has an important role in the accurate diagnosis of resistant hypertension and in supporting the rational use of drug therapy.

Estudo multicêntrico brasileiro de avaliaçäo de eficácia clínica e tolerabilidade da isradipina SRO através da monitorizaçäo ambulatorial da pressäo arterial no tratamento da hipertensäo arterial leve e moderada / Tolerability and Antihypertensive Effects of Isradipine SRO on Clinical and Ambulatorial Blood Pressure Monitoring in Essential Hypertensives. A Brazilian Multicenter Study

PURPOSE--To evaluate clinical efficacy and tolerability of isradipine SRO (I.SRO), 5 mg O.D. in essential hypertensives. METHODS--Eighty-three of 87 selected outpatients with a mean age of 51.3 years (ranging from 25 to 65), 33 male, 48 white, 29 black and others of different races, who had clinical supine and orthostatic diastolic blood pressure (DBP) > or = 95 mmHg and < or = 115 mmHg underwent the study. After a three-week wash-out period, patients received I.SRO 5 mg O.D. at 8:00 am for a six-week period (phase I). After this phase, patients received I.SRO 5 mg O.D. at 8:00 pm for a six-week period (phase II). The patients had a follow-up with an interval of three weeks and the ambulatorial blood pressure monitoring (ABPM) for 24 hours was performed with a SpaceLabs 90207 or Del Mar Avionics devices after the wash-out period and at the end of phases I and II. Measurements were performed at 15-min intervals during the day (6 am to 10 pm) and at 30-min intervals during the night (10 pm to 6 am). RESULTS--a) Heart rate did not show significant changes during the treatment period (phases I and II) when compared with the wash-out period; b) causal blood pressure: at the end of both treatment periods (phases I and II) there were statistically significant decreases (p < 0.001) in supine SBP and DBP compared with wash-out values. The mean SBP decreased from 161.6 +/- 14 to 144.3 +/- 13 mmHg (phase I) and to 141.8 +/- 13 mmHg (phase II). The mean DBP decreased from 103.4 +/- 6 to 91.2 +/- 7 (phase I) and to 89.1 +/- 8 (phase II); c) ABPM: the mean systolic 24-h ambulatory blood pressure was significantly reduced (p < 0.001) from 148.8 +/- 17 to 137.2 +/- 15 mmHg (phase I) and to 133.4 +/- 13 mmHg (phase II). The mean diastolic 24-h ambulatory blood pressure was significantly decreased (p < 0.001) from 94.3 +/- 9 to 87.0 +/- 9 (phase I) and to 85.8 +/- 8 mmHg (phase II). The mean daytime and nighttime, systolic and diastolic 24-h ambulatory blood pressure were: wash-out--152.3 +/- 17, 140.2 +/- 21, 97.4 +/- 9, 86.8 +/- 13; phase I--139.9 +/- 15, 130.0 +/- 17, 89.3 +/- 9, 81.3 +/- 10; phase II--136.7 +/- 13, 125.3 +/- 15, 88.5 +/- 8, 79.1 +/- 10, respectively. Blood pressure load (percentage of systolic blood pressure values > 140 mmHg or of diastolic blood pressure values > 90 mmHg) was significantly reduced from 62.2/62 per cent (SBP/DBP), on the was-out, to 37.9/39.9 per cent (SBP/DBP) on phase I and to 32.3/34.3 per cent (SBP/DBP) on phase II; d) side effects: most frequently related were palpitations (2.3 per cent ), headache (1.1 per cent ), flush (1 per cent ) and ankle oedema (1 per cent ). They were in general, mild-to-moderate and disappeared after the first 3 weeks of treatment. Only two patients were withdrawn because of headache (one of them with previous diagnosis of migraine). CONCLUSION--I.SRO, given by oral route, in the dosage of 5 mg O.D. as monotherapy, was effective and well tolerated, promoted significant reduction on 24-h ambulatory blood pressure attenuating the early morning rise and did not interfere with the circadian rhythm of blood pressure. No significant differences were detected in the BP lowering effect when I.SRO was given during the morning or evening. These results may indicate that the drug is as suitable as one of the first choice for treating mild and moderate hypertensive patients